Full Text
PCN3- COST ANALYSIS OF SCHIZOPHRENIA TREATMENT IN GERMANY- A COMPARISON OF OLANZAPINE, RISPERIDONE, AND HALOPERIDOL USING A CLINICAL DECISION MODEL

Abstract

Authors

A Spannheimer J Clouth KJ Gregor

Back to Volume 2, Issue 5
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×